Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03819634 · ClinicalTrials.gov registry record · NA
Longevity of Multi-Slitted Catheter With Lantern Technology
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03819634: Completed NA study, sponsored by Stanford University.
NCT03819634 is a NA study that has completed, run by Stanford University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03819634, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
To determine time to set failure when the Convatec Inset II with Lantern technology (Convatec Lantern) infusion set with multi-slitted catheter is worn for up to 10 days
Interventions
- DEVICE Inset II with Lantern Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2019-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03819634
The ClinicalTrials.gov registry entry for NCT03819634 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inset II with Lantern Technology is the first listed.
NCT03819634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03819634 about?
NCT03819634 is a clinical study titled "Longevity of Multi-Slitted Catheter With Lantern Technology". To determine time to set failure when the Convatec Inset II with Lantern technology (Convatec Lantern) infusion set with multi-slitted catheter is worn for up to 10 days
What is the current status of trial NCT03819634?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-01-25. Estimated completion is 2019-04-20.
What interventions are being tested in trial NCT03819634?
The interventions under investigation include: Inset II with Lantern Technology (DEVICE).
Who is sponsoring clinical trial NCT03819634?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.